Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Nexaph.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 101 | 99.39% | Sep 8, 2026 |
| Tirzepatide | 61 | 99.54% | Sep 9, 2026 |
| Tesamorelin | 29 | 97.37% | Sep 9, 2026 |
| BPC-157 | 17 | 99.45% | Jun 11, 2026 |
| Semaglutide | 15 | 98.41% | Mar 5, 2026 |
| Cagrilintide | 12 | 99.24% | Apr 27, 2026 |
| GHK-Cu | 11 | 99.88% | Jun 25, 2026 |
| Ipamorelin | 10 | 99.32% | Jun 5, 2026 |
| CJC-1295 No DAC | 8 | 95.56% | Sep 3, 2026 |
| MOTS-c | 5 | 98.42% | Aug 12, 2026 |
| TB-500 | 4 | 99.53% | Apr 29, 2026 |
| TB-500 Fragment 17-23 | 2 | 99.12% | Feb 1, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Tirzepatide | 2TZ3012242025 | 99.9% | Lab E | Sep 9, 2026 | verify |
| Tesamorelin | TES1003212026-20 | 99% | Lab E | Sep 9, 2026 | verify |
| Tirzepatide | NXP-2P1004162026-03 | 99.9% | Lab E | Sep 9, 2026 | verify |
| Retatrutide | NXP-3P1206222026-03 | 99.9% | Lab E | Sep 8, 2026 | verify |
| CJC-1295 No DAC | CJC0505232026-05 | 99.7% | Lab E | Sep 3, 2026 | verify |
| Tirzepatide | NXP-2P1004162026-03 | 98.25% | Lab N | Sep 2, 2026 | verify |
| Tirzepatide | NXP-2P1504032026-04 | 97.24% | Lab K | Aug 26, 2026 | verify |
| Tirzepatide | NXP-2P2005162026-04 | 99.9% | Lab E | Aug 25, 2026 | verify |
| MOTS-c | MOT1007162026-20 | 98.5% | Lab E | Aug 12, 2026 | verify |
| Tirzepatide | NXP-2P6003282026-02 | 99.9% | Lab E | Aug 3, 2026 | verify |
| Tirzepatide | NXP-2P3006232026-04 | 99.9% | Lab E | Jul 20, 2026 | verify |
| Retatrutide | NXP-3P1204012026-02 | 99.9% | Lab E | Jul 19, 2026 | verify |
| MOTS-c | MOT1003302026-18 | 98.1% | Lab E | Jul 16, 2026 | verify |
| Retatrutide | NXP-3P1204012026-02 | 98.7% | Lab E | Jul 12, 2026 | verify |
| Retatrutide | NXP-3P2405072026-01 | 99.9% | Lab E | Jun 30, 2026 | verify |
| Tesamorelin | TES1003212026-20 | 98.3% | Lab E | Jun 30, 2026 | verify |
| Retatrutide | NXP-3P2405072026-01 | 99.8% | Lab G | Jun 25, 2026 | verify |
| GHK-Cu | Ghk5002282026-13 | 99.6% | Lab G | Jun 25, 2026 | verify |
| Tirzepatide | Nxp-2p1504032026-04 | 99.8% | Lab G | Jun 25, 2026 | verify |
| GHK-Cu | GHK5002282026-13 | 99.9% | Lab E | Jun 15, 2026 | verify |
| Tesamorelin | TES1003212026-20 | 93.1% | Lab E | Jun 15, 2026 | verify |
| Tirzepatide | MXP-2P3004212026-03 | 99.9% | Lab E | Jun 14, 2026 | verify |
| Tirzepatide | NXP-2P3004212026-03 | 99.9% | Lab E | Jun 14, 2026 | verify |
| CJC-1295 No DAC | n/a | 99.9% | Lab E | Jun 11, 2026 | verify |
| Retatrutide | NXP-3P2003102026-01 | 99.7% | Lab G | Jun 11, 2026 | verify |
Showing 25 most recent of 275. Search the full database on the CoA page.
Sell or represent Nexaph? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/nexaph/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/nexaph.svg" alt="Nexaph: lab tested, 275 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.